UNICYCIVE THERAPEUTICS, INC. Other Operating Income (Expense), Net
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Other Operating Income (Expense), Net of $1.60 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2023-11-14
- UNICYCIVE THERAPEUTICS, INC. other operating income (expense), net for the quarter ending 2023-09-30 was $1.60M.
- UNICYCIVE THERAPEUTICS, INC. other operating income (expense), net for the quarter ending 2023-06-30 was $484.00K.
- UNICYCIVE THERAPEUTICS, INC. other operating income (expense), net for the quarter ending 2023-03-31 was -$10.37M.
- UNICYCIVE THERAPEUTICS, INC. other operating income (expense), net for the quarter ending 2022-09-30 was -$3.00K.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month |
|---|---|---|---|
| 2023-09-30 | $1.60M 10-Q · filed 2023-11-14 | $2.09M derived: sum of 2 quarters · filed 2023-11-14 | -$8.29M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $484.00K 10-Q · filed 2023-08-14 | -$9.89M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$10.37M 10-Q · filed 2023-05-16 | ||
| 2022-09-30 | -$3.00K 10-Q · filed 2023-11-14 | -$3.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |